nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—attention deficit hyperactivity disorder—Clonidine—glaucoma	0.488	1	CpDpCtD
Venlafaxine—SLC6A2—Clonidine—glaucoma	0.0356	0.121	CbGbCtD
Venlafaxine—CYP2D6—Carteolol—glaucoma	0.0288	0.0979	CbGbCtD
Venlafaxine—CYP2D6—Betaxolol—glaucoma	0.0195	0.0661	CbGbCtD
Venlafaxine—CYP2C19—Methazolamide—glaucoma	0.0194	0.0659	CbGbCtD
Venlafaxine—CYP2C9—Diclofenamide—glaucoma	0.0187	0.0637	CbGbCtD
Venlafaxine—CYP2C9—Dorzolamide—glaucoma	0.0181	0.0615	CbGbCtD
Venlafaxine—CYP2C19—Timolol—glaucoma	0.0165	0.0561	CbGbCtD
Venlafaxine—CYP2C9—Methazolamide—glaucoma	0.0161	0.0548	CbGbCtD
Venlafaxine—CYP2D6—Methazolamide—glaucoma	0.0148	0.0501	CbGbCtD
Venlafaxine—CYP3A4—Pilocarpine—glaucoma	0.0139	0.0472	CbGbCtD
Venlafaxine—ABCB1—Timolol—glaucoma	0.0133	0.0452	CbGbCtD
Venlafaxine—CYP2D6—Timolol—glaucoma	0.0125	0.0426	CbGbCtD
Venlafaxine—ABCB1—Clonidine—glaucoma	0.0113	0.0385	CbGbCtD
Venlafaxine—CYP3A4—Brinzolamide—glaucoma	0.0109	0.037	CbGbCtD
Venlafaxine—CYP2D6—Clonidine—glaucoma	0.0107	0.0362	CbGbCtD
Venlafaxine—CYP3A4—Dorzolamide—glaucoma	0.0105	0.0358	CbGbCtD
Venlafaxine—CYP3A4—Methazolamide—glaucoma	0.00938	0.0319	CbGbCtD
Venlafaxine—CYP3A4—Acetazolamide—glaucoma	0.0075	0.0255	CbGbCtD
Venlafaxine—CYP3A4—Clonidine—glaucoma	0.00678	0.023	CbGbCtD
Venlafaxine—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	9.57e-05	0.00298	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	9.41e-05	0.00293	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—TGFB2—glaucoma	9.22e-05	0.00287	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—SLC6A13—glaucoma	9.2e-05	0.00286	CbGpPWpGaD
Venlafaxine—SLC6A2—Monoamine Transport—TNF—glaucoma	9.07e-05	0.00282	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—OPN4—glaucoma	8.9e-05	0.00277	CbGpPWpGaD
Venlafaxine—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	8.8e-05	0.00274	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—glaucoma	8.79e-05	0.00274	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—EDN1—glaucoma	8.78e-05	0.00273	CbGpPWpGaD
Venlafaxine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.72e-05	0.00272	CbGpPWpGaD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	8.58e-05	0.00267	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.37e-05	0.00261	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HEYL—glaucoma	8.27e-05	0.00257	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—GSTM1—glaucoma	8.22e-05	0.00256	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—glaucoma	8.21e-05	0.00256	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—BDNF—glaucoma	8.17e-05	0.00254	CbGpPWpGaD
Venlafaxine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.13e-05	0.00253	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	8.04e-05	0.0025	CbGpPWpGaD
Venlafaxine—SLC6A3—Monoamine Transport—TNF—glaucoma	8.03e-05	0.0025	CbGpPWpGaD
Venlafaxine—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.02e-05	0.0025	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTGFR—glaucoma	8.01e-05	0.00249	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1A—glaucoma	7.85e-05	0.00244	CbGpPWpGaD
Venlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	7.7e-05	0.0024	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—C3—glaucoma	7.67e-05	0.00239	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—NGFR—glaucoma	7.67e-05	0.00239	CbGpPWpGaD
Venlafaxine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.48e-05	0.00233	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.42e-05	0.00231	CbGpPWpGaD
Venlafaxine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.41e-05	0.00231	CbGpPWpGaD
Venlafaxine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.38e-05	0.0023	CbGpPWpGaD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	7.37e-05	0.00229	CbGpPWpGaD
Venlafaxine—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.32e-05	0.00228	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—NTRK1—glaucoma	7.29e-05	0.00227	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—NGF—glaucoma	7.25e-05	0.00226	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—glaucoma	7.22e-05	0.00225	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	7.13e-05	0.00222	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—GSTM1—glaucoma	7.07e-05	0.0022	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—SMO—glaucoma	6.84e-05	0.00213	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	6.82e-05	0.00212	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—SLC6A1—glaucoma	6.74e-05	0.0021	CbGpPWpGaD
Venlafaxine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.59e-05	0.00205	CbGpPWpGaD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	6.35e-05	0.00198	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RPTOR—glaucoma	6.27e-05	0.00195	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—GSTM1—glaucoma	6.27e-05	0.00195	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NCK2—glaucoma	6.07e-05	0.00189	CbGpPWpGaD
Venlafaxine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.06e-05	0.00189	CbGpPWpGaD
Venlafaxine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	6.05e-05	0.00188	CbGpPWpGaD
Venlafaxine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.01e-05	0.00187	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	5.95e-05	0.00185	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—GSTT1—glaucoma	5.81e-05	0.00181	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—FAS—glaucoma	5.71e-05	0.00178	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.58e-05	0.00174	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CA5A—glaucoma	5.56e-05	0.00173	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NARFL—glaucoma	5.56e-05	0.00173	CbGpPWpGaD
Venlafaxine—Fatigue—Brinzolamide—glaucoma	5.5e-05	0.000297	CcSEcCtD
Venlafaxine—Angioedema—Clonidine—glaucoma	5.49e-05	0.000296	CcSEcCtD
Venlafaxine—Dyspnoea—Pilocarpine—glaucoma	5.47e-05	0.000296	CcSEcCtD
Venlafaxine—Pain—Brinzolamide—glaucoma	5.46e-05	0.000295	CcSEcCtD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	5.46e-05	0.0017	CbGpPWpGaD
Venlafaxine—Somnolence—Pilocarpine—glaucoma	5.45e-05	0.000295	CcSEcCtD
Venlafaxine—Depression—Timolol—glaucoma	5.45e-05	0.000294	CcSEcCtD
Venlafaxine—Pruritus—Bimatoprost—glaucoma	5.43e-05	0.000294	CcSEcCtD
Venlafaxine—Diarrhoea—Apraclonidine—glaucoma	5.42e-05	0.000293	CcSEcCtD
Venlafaxine—Malaise—Clonidine—glaucoma	5.41e-05	0.000293	CcSEcCtD
Venlafaxine—Dyspepsia—Pilocarpine—glaucoma	5.4e-05	0.000292	CcSEcCtD
Venlafaxine—Chills—Betaxolol—glaucoma	5.39e-05	0.000291	CcSEcCtD
Venlafaxine—Syncope—Clonidine—glaucoma	5.38e-05	0.000291	CcSEcCtD
Venlafaxine—Arrhythmia—Betaxolol—glaucoma	5.36e-05	0.00029	CcSEcCtD
Venlafaxine—Feeling abnormal—Dorzolamide—glaucoma	5.35e-05	0.000289	CcSEcCtD
Venlafaxine—Decreased appetite—Pilocarpine—glaucoma	5.33e-05	0.000288	CcSEcCtD
Venlafaxine—Feeling abnormal—Travoprost—glaucoma	5.33e-05	0.000288	CcSEcCtD
Venlafaxine—Conjunctivitis—Timolol—glaucoma	5.31e-05	0.000287	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Dorzolamide—glaucoma	5.31e-05	0.000287	CcSEcCtD
Venlafaxine—Alopecia—Betaxolol—glaucoma	5.31e-05	0.000287	CcSEcCtD
Venlafaxine—Palpitations—Clonidine—glaucoma	5.31e-05	0.000287	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Travoprost—glaucoma	5.29e-05	0.000286	CcSEcCtD
Venlafaxine—Loss of consciousness—Clonidine—glaucoma	5.28e-05	0.000285	CcSEcCtD
Venlafaxine—Feeling abnormal—Brinzolamide—glaucoma	5.26e-05	0.000284	CcSEcCtD
Venlafaxine—Constipation—Pilocarpine—glaucoma	5.25e-05	0.000284	CcSEcCtD
Venlafaxine—Pain—Pilocarpine—glaucoma	5.25e-05	0.000284	CcSEcCtD
Venlafaxine—Cough—Clonidine—glaucoma	5.24e-05	0.000283	CcSEcCtD
Venlafaxine—Sweating—Timolol—glaucoma	5.24e-05	0.000283	CcSEcCtD
Venlafaxine—Dizziness—Apraclonidine—glaucoma	5.24e-05	0.000283	CcSEcCtD
Venlafaxine—Erythema—Betaxolol—glaucoma	5.23e-05	0.000282	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—HDAC9—glaucoma	5.16e-05	0.00161	CbGpPWpGaD
Venlafaxine—Urticaria—Dorzolamide—glaucoma	5.16e-05	0.000279	CcSEcCtD
Venlafaxine—Epistaxis—Timolol—glaucoma	5.15e-05	0.000278	CcSEcCtD
Venlafaxine—Abdominal pain—Dorzolamide—glaucoma	5.13e-05	0.000277	CcSEcCtD
Venlafaxine—Body temperature increased—Dorzolamide—glaucoma	5.13e-05	0.000277	CcSEcCtD
Venlafaxine—Tension—Betaxolol—glaucoma	5.13e-05	0.000277	CcSEcCtD
Venlafaxine—Sinusitis—Timolol—glaucoma	5.13e-05	0.000277	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IL1A—glaucoma	5.12e-05	0.00159	CbGpPWpGaD
Venlafaxine—Dysgeusia—Betaxolol—glaucoma	5.12e-05	0.000277	CcSEcCtD
Venlafaxine—Arthralgia—Clonidine—glaucoma	5.11e-05	0.000276	CcSEcCtD
Venlafaxine—Chest pain—Clonidine—glaucoma	5.11e-05	0.000276	CcSEcCtD
Venlafaxine—Abdominal pain—Travoprost—glaucoma	5.11e-05	0.000276	CcSEcCtD
Venlafaxine—Agranulocytosis—Timolol—glaucoma	5.1e-05	0.000276	CcSEcCtD
Venlafaxine—Anxiety—Clonidine—glaucoma	5.09e-05	0.000275	CcSEcCtD
Venlafaxine—Asthenia—Acetazolamide—glaucoma	5.08e-05	0.000275	CcSEcCtD
Venlafaxine—Dizziness—Bimatoprost—glaucoma	5.08e-05	0.000274	CcSEcCtD
Venlafaxine—Nervousness—Betaxolol—glaucoma	5.08e-05	0.000274	CcSEcCtD
Venlafaxine—Urticaria—Brinzolamide—glaucoma	5.07e-05	0.000274	CcSEcCtD
Venlafaxine—Feeling abnormal—Pilocarpine—glaucoma	5.06e-05	0.000273	CcSEcCtD
Venlafaxine—Discomfort—Clonidine—glaucoma	5.05e-05	0.000273	CcSEcCtD
Venlafaxine—Vomiting—Apraclonidine—glaucoma	5.04e-05	0.000272	CcSEcCtD
Venlafaxine—Muscle spasms—Betaxolol—glaucoma	5.02e-05	0.000272	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Pilocarpine—glaucoma	5.02e-05	0.000271	CcSEcCtD
Venlafaxine—Hypersensitivity—Brimonidine—glaucoma	5.01e-05	0.000271	CcSEcCtD
Venlafaxine—Dry mouth—Clonidine—glaucoma	5e-05	0.00027	CcSEcCtD
Venlafaxine—Bradycardia—Timolol—glaucoma	4.99e-05	0.00027	CcSEcCtD
Venlafaxine—Dermatitis—Apraclonidine—glaucoma	4.99e-05	0.00027	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—EDN1—glaucoma	4.96e-05	0.00155	CbGpPWpGaD
Venlafaxine—Headache—Apraclonidine—glaucoma	4.96e-05	0.000268	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.95e-05	0.00154	CbGpPWpGaD
Venlafaxine—Confusional state—Clonidine—glaucoma	4.94e-05	0.000267	CcSEcCtD
Venlafaxine—Vision blurred—Betaxolol—glaucoma	4.93e-05	0.000266	CcSEcCtD
Venlafaxine—Rhinitis—Timolol—glaucoma	4.92e-05	0.000266	CcSEcCtD
Venlafaxine—Oedema—Clonidine—glaucoma	4.9e-05	0.000265	CcSEcCtD
Venlafaxine—Tremor—Betaxolol—glaucoma	4.9e-05	0.000265	CcSEcCtD
Venlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.89e-05	0.00152	CbGpPWpGaD
Venlafaxine—Hallucination—Timolol—glaucoma	4.88e-05	0.000264	CcSEcCtD
Venlafaxine—Asthenia—Brimonidine—glaucoma	4.88e-05	0.000264	CcSEcCtD
Venlafaxine—Infection—Clonidine—glaucoma	4.87e-05	0.000263	CcSEcCtD
Venlafaxine—Abdominal pain—Pilocarpine—glaucoma	4.85e-05	0.000262	CcSEcCtD
Venlafaxine—Body temperature increased—Pilocarpine—glaucoma	4.85e-05	0.000262	CcSEcCtD
Venlafaxine—Ill-defined disorder—Betaxolol—glaucoma	4.85e-05	0.000262	CcSEcCtD
Venlafaxine—Diarrhoea—Acetazolamide—glaucoma	4.85e-05	0.000262	CcSEcCtD
Venlafaxine—Rash—Bimatoprost—glaucoma	4.84e-05	0.000262	CcSEcCtD
Venlafaxine—Dermatitis—Bimatoprost—glaucoma	4.84e-05	0.000261	CcSEcCtD
Venlafaxine—Anaemia—Betaxolol—glaucoma	4.83e-05	0.000261	CcSEcCtD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	4.83e-05	0.0015	CbGpPWpGaD
Venlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.82e-05	0.0015	CbGpPWpGaD
Venlafaxine—Shock—Clonidine—glaucoma	4.82e-05	0.00026	CcSEcCtD
Venlafaxine—Pruritus—Brimonidine—glaucoma	4.81e-05	0.00026	CcSEcCtD
Venlafaxine—Headache—Bimatoprost—glaucoma	4.81e-05	0.00026	CcSEcCtD
Venlafaxine—Thrombocytopenia—Clonidine—glaucoma	4.8e-05	0.000259	CcSEcCtD
Venlafaxine—Hypersensitivity—Dorzolamide—glaucoma	4.78e-05	0.000258	CcSEcCtD
Venlafaxine—Tachycardia—Clonidine—glaucoma	4.78e-05	0.000258	CcSEcCtD
Venlafaxine—Hypersensitivity—Travoprost—glaucoma	4.76e-05	0.000257	CcSEcCtD
Venlafaxine—Hyperhidrosis—Clonidine—glaucoma	4.74e-05	0.000256	CcSEcCtD
Venlafaxine—Visual impairment—Timolol—glaucoma	4.73e-05	0.000255	CcSEcCtD
Venlafaxine—Malaise—Betaxolol—glaucoma	4.71e-05	0.000255	CcSEcCtD
Venlafaxine—Nausea—Apraclonidine—glaucoma	4.7e-05	0.000254	CcSEcCtD
Venlafaxine—Hypersensitivity—Brinzolamide—glaucoma	4.7e-05	0.000254	CcSEcCtD
Venlafaxine—Vertigo—Betaxolol—glaucoma	4.7e-05	0.000254	CcSEcCtD
Venlafaxine—Syncope—Betaxolol—glaucoma	4.69e-05	0.000253	CcSEcCtD
Venlafaxine—Dizziness—Acetazolamide—glaucoma	4.68e-05	0.000253	CcSEcCtD
Venlafaxine—Anorexia—Clonidine—glaucoma	4.67e-05	0.000252	CcSEcCtD
Venlafaxine—Asthenia—Dorzolamide—glaucoma	4.66e-05	0.000252	CcSEcCtD
Venlafaxine—Asthenia—Travoprost—glaucoma	4.64e-05	0.000251	CcSEcCtD
Venlafaxine—CYP2B6—Biological oxidations—CYP1B1—glaucoma	4.63e-05	0.00144	CbGpPWpGaD
Venlafaxine—Palpitations—Betaxolol—glaucoma	4.62e-05	0.00025	CcSEcCtD
Venlafaxine—Pruritus—Dorzolamide—glaucoma	4.59e-05	0.000248	CcSEcCtD
Venlafaxine—Loss of consciousness—Betaxolol—glaucoma	4.59e-05	0.000248	CcSEcCtD
Venlafaxine—Asthenia—Brinzolamide—glaucoma	4.58e-05	0.000247	CcSEcCtD
Venlafaxine—Hypotension—Clonidine—glaucoma	4.58e-05	0.000247	CcSEcCtD
Venlafaxine—Pruritus—Travoprost—glaucoma	4.57e-05	0.000247	CcSEcCtD
Venlafaxine—Tinnitus—Timolol—glaucoma	4.57e-05	0.000247	CcSEcCtD
Venlafaxine—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	4.57e-05	0.00142	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—FAS—glaucoma	4.56e-05	0.00142	CbGpPWpGaD
Venlafaxine—Cough—Betaxolol—glaucoma	4.56e-05	0.000246	CcSEcCtD
Venlafaxine—Nausea—Bimatoprost—glaucoma	4.56e-05	0.000246	CcSEcCtD
Venlafaxine—Cardiac disorder—Timolol—glaucoma	4.55e-05	0.000246	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.55e-05	0.00142	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Pilocarpine—glaucoma	4.52e-05	0.000244	CcSEcCtD
Venlafaxine—Pruritus—Brinzolamide—glaucoma	4.52e-05	0.000244	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—EDN1—glaucoma	4.51e-05	0.0014	CbGpPWpGaD
Venlafaxine—Vomiting—Acetazolamide—glaucoma	4.5e-05	0.000243	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—C3—glaucoma	4.5e-05	0.0014	CbGpPWpGaD
Venlafaxine—Dizziness—Brimonidine—glaucoma	4.5e-05	0.000243	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Clonidine—glaucoma	4.46e-05	0.000241	CcSEcCtD
Venlafaxine—Chest pain—Betaxolol—glaucoma	4.45e-05	0.00024	CcSEcCtD
Venlafaxine—Arthralgia—Betaxolol—glaucoma	4.45e-05	0.00024	CcSEcCtD
Venlafaxine—Myalgia—Betaxolol—glaucoma	4.45e-05	0.00024	CcSEcCtD
Venlafaxine—Diarrhoea—Dorzolamide—glaucoma	4.44e-05	0.00024	CcSEcCtD
Venlafaxine—Headache—Acetazolamide—glaucoma	4.44e-05	0.00024	CcSEcCtD
Venlafaxine—Anxiety—Betaxolol—glaucoma	4.43e-05	0.00024	CcSEcCtD
Venlafaxine—Insomnia—Clonidine—glaucoma	4.43e-05	0.000239	CcSEcCtD
Venlafaxine—Diarrhoea—Travoprost—glaucoma	4.42e-05	0.000239	CcSEcCtD
Venlafaxine—Asthenia—Pilocarpine—glaucoma	4.4e-05	0.000238	CcSEcCtD
Venlafaxine—Paraesthesia—Clonidine—glaucoma	4.4e-05	0.000238	CcSEcCtD
Venlafaxine—Discomfort—Betaxolol—glaucoma	4.4e-05	0.000238	CcSEcCtD
Venlafaxine—CYP2C19—Biological oxidations—GSTT1—glaucoma	4.39e-05	0.00137	CbGpPWpGaD
Venlafaxine—Arrhythmia—Timolol—glaucoma	4.38e-05	0.000237	CcSEcCtD
Venlafaxine—Dyspnoea—Clonidine—glaucoma	4.37e-05	0.000236	CcSEcCtD
Venlafaxine—Diarrhoea—Brinzolamide—glaucoma	4.37e-05	0.000236	CcSEcCtD
Venlafaxine—Somnolence—Clonidine—glaucoma	4.36e-05	0.000235	CcSEcCtD
Venlafaxine—Dry mouth—Betaxolol—glaucoma	4.35e-05	0.000235	CcSEcCtD
Venlafaxine—Pruritus—Pilocarpine—glaucoma	4.34e-05	0.000235	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—C3—glaucoma	4.34e-05	0.00135	CbGpPWpGaD
Venlafaxine—Alopecia—Timolol—glaucoma	4.33e-05	0.000234	CcSEcCtD
Venlafaxine—Confusional state—Betaxolol—glaucoma	4.3e-05	0.000232	CcSEcCtD
Venlafaxine—Dizziness—Dorzolamide—glaucoma	4.29e-05	0.000232	CcSEcCtD
Venlafaxine—Rash—Brimonidine—glaucoma	4.29e-05	0.000232	CcSEcCtD
Venlafaxine—Dermatitis—Brimonidine—glaucoma	4.28e-05	0.000231	CcSEcCtD
Venlafaxine—Dizziness—Travoprost—glaucoma	4.28e-05	0.000231	CcSEcCtD
Venlafaxine—Erythema—Timolol—glaucoma	4.27e-05	0.000231	CcSEcCtD
Venlafaxine—Oedema—Betaxolol—glaucoma	4.27e-05	0.00023	CcSEcCtD
Venlafaxine—Headache—Brimonidine—glaucoma	4.26e-05	0.00023	CcSEcCtD
Venlafaxine—Decreased appetite—Clonidine—glaucoma	4.26e-05	0.00023	CcSEcCtD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	4.24e-05	0.00132	CbGpPWpGaD
Venlafaxine—Infection—Betaxolol—glaucoma	4.24e-05	0.000229	CcSEcCtD
Venlafaxine—Fatigue—Clonidine—glaucoma	4.22e-05	0.000228	CcSEcCtD
Venlafaxine—Dizziness—Brinzolamide—glaucoma	4.22e-05	0.000228	CcSEcCtD
Venlafaxine—Nausea—Acetazolamide—glaucoma	4.21e-05	0.000227	CcSEcCtD
Venlafaxine—Diarrhoea—Pilocarpine—glaucoma	4.2e-05	0.000227	CcSEcCtD
Venlafaxine—Shock—Betaxolol—glaucoma	4.2e-05	0.000227	CcSEcCtD
Venlafaxine—Tension—Timolol—glaucoma	4.19e-05	0.000226	CcSEcCtD
Venlafaxine—Pain—Clonidine—glaucoma	4.19e-05	0.000226	CcSEcCtD
Venlafaxine—Constipation—Clonidine—glaucoma	4.19e-05	0.000226	CcSEcCtD
Venlafaxine—Dysgeusia—Timolol—glaucoma	4.18e-05	0.000226	CcSEcCtD
Venlafaxine—Thrombocytopenia—Betaxolol—glaucoma	4.18e-05	0.000226	CcSEcCtD
Venlafaxine—Tachycardia—Betaxolol—glaucoma	4.16e-05	0.000225	CcSEcCtD
Venlafaxine—Nervousness—Timolol—glaucoma	4.15e-05	0.000224	CcSEcCtD
Venlafaxine—Vomiting—Dorzolamide—glaucoma	4.13e-05	0.000223	CcSEcCtD
Venlafaxine—Hyperhidrosis—Betaxolol—glaucoma	4.12e-05	0.000223	CcSEcCtD
Venlafaxine—Rash—Dorzolamide—glaucoma	4.09e-05	0.000221	CcSEcCtD
Venlafaxine—Dermatitis—Dorzolamide—glaucoma	4.09e-05	0.000221	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.09e-05	0.00127	CbGpPWpGaD
Venlafaxine—Rash—Travoprost—glaucoma	4.08e-05	0.00022	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—CA5A—glaucoma	4.08e-05	0.00127	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NARFL—glaucoma	4.08e-05	0.00127	CbGpPWpGaD
Venlafaxine—Dermatitis—Travoprost—glaucoma	4.07e-05	0.00022	CcSEcCtD
Venlafaxine—Headache—Dorzolamide—glaucoma	4.07e-05	0.00022	CcSEcCtD
Venlafaxine—Anorexia—Betaxolol—glaucoma	4.07e-05	0.00022	CcSEcCtD
Venlafaxine—Vomiting—Brinzolamide—glaucoma	4.06e-05	0.000219	CcSEcCtD
Venlafaxine—Dizziness—Pilocarpine—glaucoma	4.06e-05	0.000219	CcSEcCtD
Venlafaxine—Headache—Travoprost—glaucoma	4.05e-05	0.000219	CcSEcCtD
Venlafaxine—CYP2D6—Biological oxidations—GSTT1—glaucoma	4.04e-05	0.00126	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SMO—glaucoma	4.04e-05	0.00126	CbGpPWpGaD
Venlafaxine—Nausea—Brimonidine—glaucoma	4.04e-05	0.000218	CcSEcCtD
Venlafaxine—Feeling abnormal—Clonidine—glaucoma	4.04e-05	0.000218	CcSEcCtD
Venlafaxine—Rash—Brinzolamide—glaucoma	4.02e-05	0.000217	CcSEcCtD
Venlafaxine—Vision blurred—Timolol—glaucoma	4.02e-05	0.000217	CcSEcCtD
Venlafaxine—Dermatitis—Brinzolamide—glaucoma	4.02e-05	0.000217	CcSEcCtD
Venlafaxine—CYP2C9—Biological oxidations—GSTT1—glaucoma	4.01e-05	0.00125	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Clonidine—glaucoma	4.01e-05	0.000216	CcSEcCtD
Venlafaxine—Headache—Brinzolamide—glaucoma	4e-05	0.000216	CcSEcCtD
Venlafaxine—Hypotension—Betaxolol—glaucoma	3.99e-05	0.000215	CcSEcCtD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	3.98e-05	0.00124	CbGpPWpGaD
Venlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.96e-05	0.00123	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—C3—glaucoma	3.94e-05	0.00123	CbGpPWpGaD
Venlafaxine—Angioedema—Timolol—glaucoma	3.9e-05	0.000211	CcSEcCtD
Venlafaxine—Vomiting—Pilocarpine—glaucoma	3.9e-05	0.000211	CcSEcCtD
Venlafaxine—Urticaria—Clonidine—glaucoma	3.89e-05	0.00021	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Betaxolol—glaucoma	3.89e-05	0.00021	CcSEcCtD
Venlafaxine—Body temperature increased—Clonidine—glaucoma	3.87e-05	0.000209	CcSEcCtD
Venlafaxine—Abdominal pain—Clonidine—glaucoma	3.87e-05	0.000209	CcSEcCtD
Venlafaxine—Rash—Pilocarpine—glaucoma	3.87e-05	0.000209	CcSEcCtD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	3.87e-05	0.0012	CbGpPWpGaD
Venlafaxine—Dermatitis—Pilocarpine—glaucoma	3.86e-05	0.000209	CcSEcCtD
Venlafaxine—Insomnia—Betaxolol—glaucoma	3.86e-05	0.000208	CcSEcCtD
Venlafaxine—Nausea—Dorzolamide—glaucoma	3.86e-05	0.000208	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	3.85e-05	0.0012	CbGpPWpGaD
Venlafaxine—Headache—Pilocarpine—glaucoma	3.84e-05	0.000208	CcSEcCtD
Venlafaxine—Nausea—Travoprost—glaucoma	3.84e-05	0.000208	CcSEcCtD
Venlafaxine—Vertigo—Timolol—glaucoma	3.84e-05	0.000207	CcSEcCtD
Venlafaxine—Paraesthesia—Betaxolol—glaucoma	3.83e-05	0.000207	CcSEcCtD
Venlafaxine—Syncope—Timolol—glaucoma	3.83e-05	0.000207	CcSEcCtD
Venlafaxine—Dyspnoea—Betaxolol—glaucoma	3.8e-05	0.000205	CcSEcCtD
Venlafaxine—Nausea—Brinzolamide—glaucoma	3.79e-05	0.000205	CcSEcCtD
Venlafaxine—Palpitations—Timolol—glaucoma	3.77e-05	0.000204	CcSEcCtD
Venlafaxine—Dyspepsia—Betaxolol—glaucoma	3.75e-05	0.000203	CcSEcCtD
Venlafaxine—Loss of consciousness—Timolol—glaucoma	3.75e-05	0.000203	CcSEcCtD
Venlafaxine—Cough—Timolol—glaucoma	3.73e-05	0.000201	CcSEcCtD
Venlafaxine—Decreased appetite—Betaxolol—glaucoma	3.71e-05	0.0002	CcSEcCtD
Venlafaxine—CYP2B6—Biological oxidations—GSTM1—glaucoma	3.7e-05	0.00115	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NTRK2—glaucoma	3.69e-05	0.00115	CbGpPWpGaD
Venlafaxine—Hypertension—Timolol—glaucoma	3.69e-05	0.000199	CcSEcCtD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	3.69e-05	0.00115	CbGpPWpGaD
Venlafaxine—Fatigue—Betaxolol—glaucoma	3.68e-05	0.000199	CcSEcCtD
Venlafaxine—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	3.65e-05	0.00114	CbGpPWpGaD
Venlafaxine—Pain—Betaxolol—glaucoma	3.65e-05	0.000197	CcSEcCtD
Venlafaxine—Constipation—Betaxolol—glaucoma	3.65e-05	0.000197	CcSEcCtD
Venlafaxine—Nausea—Pilocarpine—glaucoma	3.64e-05	0.000197	CcSEcCtD
Venlafaxine—Chest pain—Timolol—glaucoma	3.63e-05	0.000196	CcSEcCtD
Venlafaxine—Arthralgia—Timolol—glaucoma	3.63e-05	0.000196	CcSEcCtD
Venlafaxine—Myalgia—Timolol—glaucoma	3.63e-05	0.000196	CcSEcCtD
Venlafaxine—Anxiety—Timolol—glaucoma	3.62e-05	0.000196	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.62e-05	0.00113	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Clonidine—glaucoma	3.61e-05	0.000195	CcSEcCtD
Venlafaxine—Discomfort—Timolol—glaucoma	3.59e-05	0.000194	CcSEcCtD
Venlafaxine—Dry mouth—Timolol—glaucoma	3.56e-05	0.000192	CcSEcCtD
Venlafaxine—Asthenia—Clonidine—glaucoma	3.52e-05	0.00019	CcSEcCtD
Venlafaxine—Feeling abnormal—Betaxolol—glaucoma	3.51e-05	0.00019	CcSEcCtD
Venlafaxine—Confusional state—Timolol—glaucoma	3.51e-05	0.00019	CcSEcCtD
Venlafaxine—CYP2C19—Biological oxidations—CYP1B1—glaucoma	3.5e-05	0.00109	CbGpPWpGaD
Venlafaxine—Anaphylactic shock—Timolol—glaucoma	3.48e-05	0.000188	CcSEcCtD
Venlafaxine—Oedema—Timolol—glaucoma	3.48e-05	0.000188	CcSEcCtD
Venlafaxine—Pruritus—Clonidine—glaucoma	3.47e-05	0.000187	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.46e-05	0.00108	CbGpPWpGaD
Venlafaxine—Infection—Timolol—glaucoma	3.46e-05	0.000187	CcSEcCtD
Venlafaxine—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	3.45e-05	0.00108	CbGpPWpGaD
Venlafaxine—Shock—Timolol—glaucoma	3.43e-05	0.000185	CcSEcCtD
Venlafaxine—Urticaria—Betaxolol—glaucoma	3.39e-05	0.000183	CcSEcCtD
Venlafaxine—Body temperature increased—Betaxolol—glaucoma	3.37e-05	0.000182	CcSEcCtD
Venlafaxine—Hyperhidrosis—Timolol—glaucoma	3.37e-05	0.000182	CcSEcCtD
Venlafaxine—Diarrhoea—Clonidine—glaucoma	3.35e-05	0.000181	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.33e-05	0.00104	CbGpPWpGaD
Venlafaxine—Anorexia—Timolol—glaucoma	3.32e-05	0.000179	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.27e-05	0.00102	CbGpPWpGaD
Venlafaxine—Hypotension—Timolol—glaucoma	3.26e-05	0.000176	CcSEcCtD
Venlafaxine—Dizziness—Clonidine—glaucoma	3.24e-05	0.000175	CcSEcCtD
Venlafaxine—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.22e-05	0.001	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.19e-05	0.000994	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.18e-05	0.000989	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Timolol—glaucoma	3.17e-05	0.000172	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—NGFR—glaucoma	3.17e-05	0.000987	CbGpPWpGaD
Venlafaxine—Insomnia—Timolol—glaucoma	3.15e-05	0.00017	CcSEcCtD
Venlafaxine—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.15e-05	0.00098	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Betaxolol—glaucoma	3.14e-05	0.00017	CcSEcCtD
Venlafaxine—Paraesthesia—Timolol—glaucoma	3.13e-05	0.000169	CcSEcCtD
Venlafaxine—Vomiting—Clonidine—glaucoma	3.12e-05	0.000168	CcSEcCtD
Venlafaxine—Dyspnoea—Timolol—glaucoma	3.11e-05	0.000168	CcSEcCtD
Venlafaxine—Somnolence—Timolol—glaucoma	3.1e-05	0.000167	CcSEcCtD
Venlafaxine—Rash—Clonidine—glaucoma	3.09e-05	0.000167	CcSEcCtD
Venlafaxine—Dermatitis—Clonidine—glaucoma	3.09e-05	0.000167	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism—CA5A—glaucoma	3.08e-05	0.000959	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NARFL—glaucoma	3.08e-05	0.000959	CbGpPWpGaD
Venlafaxine—Headache—Clonidine—glaucoma	3.07e-05	0.000166	CcSEcCtD
Venlafaxine—Dyspepsia—Timolol—glaucoma	3.07e-05	0.000166	CcSEcCtD
Venlafaxine—Asthenia—Betaxolol—glaucoma	3.06e-05	0.000165	CcSEcCtD
Venlafaxine—Decreased appetite—Timolol—glaucoma	3.03e-05	0.000164	CcSEcCtD
Venlafaxine—Pruritus—Betaxolol—glaucoma	3.02e-05	0.000163	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—NTRK1—glaucoma	3.01e-05	0.000938	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NARFL—glaucoma	3.01e-05	0.000936	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CA5A—glaucoma	3.01e-05	0.000936	CbGpPWpGaD
Venlafaxine—Fatigue—Timolol—glaucoma	3e-05	0.000162	CcSEcCtD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.98e-05	0.000928	CbGpPWpGaD
Venlafaxine—Pain—Timolol—glaucoma	2.98e-05	0.000161	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—glaucoma	2.97e-05	0.000924	CbGpPWpGaD
Venlafaxine—Diarrhoea—Betaxolol—glaucoma	2.92e-05	0.000158	CcSEcCtD
Venlafaxine—Nausea—Clonidine—glaucoma	2.91e-05	0.000157	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	2.87e-05	0.000895	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Timolol—glaucoma	2.87e-05	0.000155	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Timolol—glaucoma	2.85e-05	0.000154	CcSEcCtD
Venlafaxine—CYP2D6—Metabolism—CA5A—glaucoma	2.83e-05	0.000882	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NARFL—glaucoma	2.83e-05	0.000882	CbGpPWpGaD
Venlafaxine—Dizziness—Betaxolol—glaucoma	2.82e-05	0.000152	CcSEcCtD
Venlafaxine—CYP2C9—Metabolism—NARFL—glaucoma	2.81e-05	0.000874	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CA5A—glaucoma	2.81e-05	0.000874	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—GSTM1—glaucoma	2.8e-05	0.000871	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CDKN2B—glaucoma	2.78e-05	0.000864	CbGpPWpGaD
Venlafaxine—Urticaria—Timolol—glaucoma	2.77e-05	0.00015	CcSEcCtD
Venlafaxine—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.76e-05	0.000859	CbGpPWpGaD
Venlafaxine—Abdominal pain—Timolol—glaucoma	2.75e-05	0.000149	CcSEcCtD
Venlafaxine—Body temperature increased—Timolol—glaucoma	2.75e-05	0.000149	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—CA1—glaucoma	2.72e-05	0.000845	CbGpPWpGaD
Venlafaxine—Vomiting—Betaxolol—glaucoma	2.71e-05	0.000147	CcSEcCtD
Venlafaxine—Rash—Betaxolol—glaucoma	2.69e-05	0.000145	CcSEcCtD
Venlafaxine—Dermatitis—Betaxolol—glaucoma	2.69e-05	0.000145	CcSEcCtD
Venlafaxine—Headache—Betaxolol—glaucoma	2.67e-05	0.000144	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—EDN1—glaucoma	2.66e-05	0.000829	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	2.65e-05	0.000825	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.64e-05	0.000823	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.63e-05	0.000819	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CTSA—glaucoma	2.63e-05	0.000819	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.61e-05	0.000813	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.57e-05	0.000801	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Timolol—glaucoma	2.57e-05	0.000139	CcSEcCtD
Venlafaxine—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.55e-05	0.000795	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.54e-05	0.00079	CbGpPWpGaD
Venlafaxine—Nausea—Betaxolol—glaucoma	2.53e-05	0.000137	CcSEcCtD
Venlafaxine—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.52e-05	0.000784	CbGpPWpGaD
Venlafaxine—Asthenia—Timolol—glaucoma	2.5e-05	0.000135	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—CA2—glaucoma	2.48e-05	0.000773	CbGpPWpGaD
Venlafaxine—Pruritus—Timolol—glaucoma	2.47e-05	0.000133	CcSEcCtD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.46e-05	0.000766	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NGF—glaucoma	2.45e-05	0.000762	CbGpPWpGaD
Venlafaxine—Diarrhoea—Timolol—glaucoma	2.38e-05	0.000129	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—C3—glaucoma	2.33e-05	0.000724	CbGpPWpGaD
Venlafaxine—Dizziness—Timolol—glaucoma	2.3e-05	0.000125	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—VEGFA—glaucoma	2.26e-05	0.000704	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.25e-05	0.000701	CbGpPWpGaD
Venlafaxine—Vomiting—Timolol—glaucoma	2.22e-05	0.00012	CcSEcCtD
Venlafaxine—Rash—Timolol—glaucoma	2.2e-05	0.000119	CcSEcCtD
Venlafaxine—Dermatitis—Timolol—glaucoma	2.2e-05	0.000119	CcSEcCtD
Venlafaxine—Headache—Timolol—glaucoma	2.18e-05	0.000118	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—APOE—glaucoma	2.17e-05	0.000674	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CAV1—glaucoma	2.15e-05	0.000668	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—glaucoma	2.14e-05	0.000665	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.11e-05	0.000655	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.08e-05	0.000646	CbGpPWpGaD
Venlafaxine—Nausea—Timolol—glaucoma	2.07e-05	0.000112	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—FN1—glaucoma	2.04e-05	0.000636	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—BAD—glaucoma	2.02e-05	0.000628	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CA1—glaucoma	1.99e-05	0.00062	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—TNF—glaucoma	1.94e-05	0.000603	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CTSA—glaucoma	1.93e-05	0.0006	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.93e-05	0.0006	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CA5A—glaucoma	1.85e-05	0.000577	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NARFL—glaucoma	1.85e-05	0.000577	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CA2—glaucoma	1.82e-05	0.000567	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.8e-05	0.00056	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TXN—glaucoma	1.75e-05	0.000545	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.68e-05	0.000524	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.66e-05	0.000517	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NOS3—glaucoma	1.62e-05	0.000505	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CA1—glaucoma	1.5e-05	0.000468	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CA1—glaucoma	1.47e-05	0.000457	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CTSA—glaucoma	1.46e-05	0.000453	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CTSA—glaucoma	1.42e-05	0.000443	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.42e-05	0.000441	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CDKN1B—glaucoma	1.41e-05	0.000438	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CA1—glaucoma	1.38e-05	0.000431	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CA2—glaucoma	1.38e-05	0.000428	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CA1—glaucoma	1.37e-05	0.000427	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTT1—glaucoma	1.36e-05	0.000422	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.34e-05	0.000419	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.34e-05	0.000419	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CA2—glaucoma	1.34e-05	0.000418	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.34e-05	0.000418	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CTSA—glaucoma	1.34e-05	0.000417	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CTSA—glaucoma	1.33e-05	0.000413	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MMP9—glaucoma	1.3e-05	0.000405	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TXN—glaucoma	1.28e-05	0.000399	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CA2—glaucoma	1.27e-05	0.000394	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CA2—glaucoma	1.25e-05	0.00039	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.23e-05	0.000382	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.23e-05	0.000382	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VEGFA—glaucoma	1.17e-05	0.000364	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.12e-05	0.000347	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP1B1—glaucoma	1.08e-05	0.000337	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ABCA1—glaucoma	1.08e-05	0.000337	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTT1—glaucoma	9.94e-06	0.00031	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TXN—glaucoma	9.69e-06	0.000302	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	9.56e-06	0.000298	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TXN—glaucoma	9.46e-06	0.000294	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CA1—glaucoma	9.04e-06	0.000282	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TXN—glaucoma	8.91e-06	0.000278	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.84e-06	0.000275	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TXN—glaucoma	8.84e-06	0.000275	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—glaucoma	8.83e-06	0.000275	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.76e-06	0.000273	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CTSA—glaucoma	8.76e-06	0.000273	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTM1—glaucoma	8.64e-06	0.000269	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	8.43e-06	0.000262	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CA2—glaucoma	8.27e-06	0.000258	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.06e-06	0.000251	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.99e-06	0.000249	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP1B1—glaucoma	7.92e-06	0.000247	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ABCA1—glaucoma	7.92e-06	0.000247	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—MTHFR—glaucoma	7.64e-06	0.000238	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTT1—glaucoma	7.51e-06	0.000234	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTT1—glaucoma	7.33e-06	0.000228	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—APOE—glaucoma	7.11e-06	0.000221	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CAV1—glaucoma	7.04e-06	0.000219	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTT1—glaucoma	6.91e-06	0.000215	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTT1—glaucoma	6.85e-06	0.000213	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTM1—glaucoma	6.33e-06	0.000197	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.06e-06	0.000189	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP1B1—glaucoma	5.99e-06	0.000186	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ABCA1—glaucoma	5.99e-06	0.000186	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ABCA1—glaucoma	5.84e-06	0.000182	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP1B1—glaucoma	5.84e-06	0.000182	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TXN—glaucoma	5.83e-06	0.000181	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—MTHFR—glaucoma	5.6e-06	0.000174	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.52e-06	0.000172	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ABCA1—glaucoma	5.51e-06	0.000171	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP1B1—glaucoma	5.51e-06	0.000171	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ABCA1—glaucoma	5.46e-06	0.00017	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP1B1—glaucoma	5.46e-06	0.00017	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NOS3—glaucoma	5.33e-06	0.000166	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—APOE—glaucoma	5.21e-06	0.000162	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CAV1—glaucoma	5.16e-06	0.000161	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS2—glaucoma	4.87e-06	0.000152	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTM1—glaucoma	4.79e-06	0.000149	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTM1—glaucoma	4.67e-06	0.000145	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTT1—glaucoma	4.52e-06	0.000141	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTM1—glaucoma	4.4e-06	0.000137	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTM1—glaucoma	4.36e-06	0.000136	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—MTHFR—glaucoma	4.23e-06	0.000132	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—MTHFR—glaucoma	4.13e-06	0.000129	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—APOE—glaucoma	3.94e-06	0.000123	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NOS3—glaucoma	3.9e-06	0.000122	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CAV1—glaucoma	3.9e-06	0.000121	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—MTHFR—glaucoma	3.89e-06	0.000121	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—MTHFR—glaucoma	3.86e-06	0.00012	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—APOE—glaucoma	3.84e-06	0.00012	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CAV1—glaucoma	3.81e-06	0.000119	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—APOE—glaucoma	3.62e-06	0.000113	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ABCA1—glaucoma	3.6e-06	0.000112	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP1B1—glaucoma	3.6e-06	0.000112	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—APOE—glaucoma	3.59e-06	0.000112	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CAV1—glaucoma	3.59e-06	0.000112	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS2—glaucoma	3.57e-06	0.000111	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CAV1—glaucoma	3.56e-06	0.000111	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NOS3—glaucoma	2.95e-06	9.19e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NOS3—glaucoma	2.88e-06	8.97e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTM1—glaucoma	2.88e-06	8.96e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NOS3—glaucoma	2.71e-06	8.45e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS2—glaucoma	2.7e-06	8.4e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NOS3—glaucoma	2.69e-06	8.38e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS2—glaucoma	2.63e-06	8.2e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—MTHFR—glaucoma	2.54e-06	7.92e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS2—glaucoma	2.48e-06	7.73e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS2—glaucoma	2.46e-06	7.66e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—APOE—glaucoma	2.37e-06	7.37e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CAV1—glaucoma	2.35e-06	7.3e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NOS3—glaucoma	1.77e-06	5.52e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS2—glaucoma	1.62e-06	5.05e-05	CbGpPWpGaD
